Literature DB >> 1713140

Endogenous retroviral LTR DNA sequences as markers for individual human chromosomes.

N Nakamura1, H Sugino, K Takahara, C Jin, S Fukushige, K Matsubara.   

Abstract

The human genome carries multiple copies of sequences related to endogenous retroviral genomes that include long terminal repeat (LTR) sequences. We used the LTR of one such viral genome, called HERV-A, as a probe in Southern analysis to examine the distribution profiles of the hybridizing DNA in the genomes of twelve human x rodent hybrid cell lines carrying one or a few human chromosomes, and in the DNA samples prepared from six sorted, individual chromosomes. The HERV-A sequence was found to be widely distributed among different chromosomes and the Southern patterns for chromosomes 5, the X, and the Y, each obtained in duplicate from independently prepared cell lines or sorted chromosomes, were matched. Chromosome-specific Southern profiles can be used to monitor chromosomes in hybrid cells or to characterize chromosome aberrations, such as deletions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713140     DOI: 10.1159/000133105

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  4 in total

1.  Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells.

Authors:  S Fukushige; B Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants.

Authors:  B Bethke; B Sauer
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 3.  Evolution and biological significance of human retroelements.

Authors:  C Leib-Mösch; W Seifarth
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

4.  Genomic targeting with purified Cre recombinase.

Authors:  W Baubonis; B Sauer
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.